- Rouz Darou Pharmaceutial Co. released its 3Q1393 (year ending 20 Mar 2015) report. Rouzdarou’s main productions include variety of tablets and S.C. Tabs, Capsules and powders. The company sales all its products domestically while some parts of its ingredients are imported. last year the company imported 33% of its ingredients which have increased to 39% in 9 months period this year. The company predicted to increase its production by 10 % this year compared with last year and it could cover more than 74% of this forecasted amount. Generally, the company’s production in 3Q1393 has improved 9 percent compared with same period last year. The company also forecasted 22 and 26 percent increase respectively in its volume and value of sales for Y1393 compared with last year. Although the company’s return in Y1392 jumped by 293 percent compared with Y1391, it couldn’t maintain the same trend for this year. The EPS has been decreased by 30 percent to 263 IRR in 3Q1393 compared with same period last year. In current year budget, the company’s EPS is forecasted 29 percent less than last year EPS. In next year budget the company has reduced its EPS by 48 percent to 182 IRR. The reasons for this negative adjustment have not announced yet.
